On Weight Watchers (WW), liquor points can add up quickly. Using zero point mixers are about to transform your cocktail ...

Almost half of the 1.6 million people using weight-loss jabs admit to either trying dosing ‘hacks’, or turning to unlicensed ...

The MarketWatch News Department was not involved in the creation of this content.-- Novo Nordisk's first big game spot introduces America to the FDA-approved Wegovy(R) pill -- the ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. Sometimes, portion control isn’t enough. You know ...

Kingdom Capital Advisors, a private investment firm, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. The firm started the business four years ago with a ...

Americans can now purchase a starter dose of Novo Nordisk’s weight loss drug Wegovy in pill form, the company announced Monday, pledging widespread availability. The 1.5 milligram starter dose of a ...

Weight-loss drug Wegovy is now available in the form of a pill in the United States, the Scandinavian drug-maker Novo Nordisk announced on Monday, Jan. 5. The first-of-its kind pill offers 1.5 and 4 ...

GoodRX, Weight Watchers and LifeMD all said they will offer Novo Nordisk's new weight-loss pill, Wegovy, on their respective platforms. U.S. regulators approved the new pill last month. At that time, ...

Weight Watchers is putting on some weight, at least in its new logo (right, above). The heavier-looking “modern topography…conveys stability, trust, and the brand’s reputation for sustainable health ...

WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

WW International (WW), popularly known as Weight Watchers, plans to sell Novo Nordisk's (NVO) weight loss drug Wegovy in pill form if it launches in the U.S. next year, Reuters reported. "We have been ...